Healthcare Services

Food Allergy Treatment Market to Reach $12.72B by 2030 at 10.6% CAGR

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Food Allergy Treatment Market Projected To Reach By 2030?

The food allergy treatment market has experienced substantial expansion in recent years. It is projected to increase from $7.6 billion in 2025 to $8.5 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.8%. This historical growth can be attributed to factors such as an increase in food allergy prevalence, the widespread availability of antihistamines, the adoption of epinephrine therapy, higher rates of allergy diagnosis, and the development of clinical guidelines.

The food allergy treatment market is projected to experience substantial expansion in the coming years, reaching a valuation of $12.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.6%. This anticipated growth during the forecast period is primarily driven by advancements in oral immunotherapy, the broader availability of biologic treatments, an increase in pediatric allergy care, the rising need for ongoing allergy management solutions, and improved access to healthcare services. Key trends emerging during this period encompass the growing acceptance of immunotherapy-based therapies, a greater utilization of epinephrine auto-injectors, an intensified focus on proactive allergy prevention, the development of more personalized allergy treatment strategies, and heightened public awareness regarding food allergy conditions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/food-allergy-treatment-global-market-report

What Key Factors Are Shaping The Food Allergy Treatment Market Landscape?

The escalating incidence of food adulteration is anticipated to fuel the expansion of the food allergy treatment market in the foreseeable future. Food adulteration describes the deliberate modification of food items, involving either the addition of substandard, detrimental, or illicit substances, or the extraction of essential components, primarily to boost volume or improve aesthetic appeal, frequently jeopardizing both quality and safety. This phenomenon is on the rise, attributed to several factors including economic gain, intricate supply chain complexities, insufficient regulatory oversight, advancements in technology, the growing demand for convenience, globalization, environmental influences, consumer awareness, pressure for higher profit margins, and inadequate enforcement of existing regulations. A significant driver behind the expansion of food adulteration is the heightened consumer demand for more affordable goods, which motivates producers to reduce expenses and optimize profits through unscrupulous methods. Such practices can elevate the potential for allergic reactions, either by inadvertently incorporating allergens into food items or by undermining the overall safety and integrity of the food supply chain. As an illustration, in 2023, data from the FDA CORE Network, a U.S.-based government agency, indicated its team assessed 69 incidents, addressed 25, and disseminated 10 public health advisories. This contrasts with 2022, when they recorded 65 incidents, 28 responses, and 11 advisories. Consequently, the escalating problem of food adulteration is a key catalyst for the expansion of the food allergy treatment market.

How Is The Food Allergy Treatment Market Segmented Across Different Segment Categories?

The food allergy treatment market covered in this report is segmented –

1) By Drug Type: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anti-Cholinergic, Immuno-Modulators, Epinephrine, Immunotherapy

2) By Route Of Administration: Parenteral, Oral

3) By Allergen Type: Dairy Products, Poultry Product, Tree Nuts, Peanuts, Shellfish, Wheat, Soys, Other Allergens

4) By End-Use: Hospital Pharmacies, Retail Pharmacies, Other End-Uses

Subsegments:

1) By Antihistamines: Oral Antihistamines, Topical Antihistamines, Intranasal Antihistamines

2) By Decongestants: Oral Decongestants, Nasal Decongestants

3) By Corticosteroids: Oral Corticosteroids, Topical Corticosteroids, Intranasal Corticosteroids

4) By Mast Cell Stabilizers: Cromolyn Sodium, Nedocromil

5) By Leukotriene Inhibitors: Montelukast, Zafirlukast

6) By Nasal Anti-Cholinergic: Ipratropium Bromide

7) By Immuno-Modulators: Omalizumab, Dupilumab

8) By Epinephrine: Injectable Epinephrine, Auto-Injectors

9) By Immunotherapy: Oral Immunotherapy (OIT), Sublingual Immunotherapy (SLIT), Epicutaneous Immunotherapy (EPIT)

What Market Trends Are Affecting The Food Allergy Treatment Market?

Leading corporations within the food allergy treatment market are actively developing innovative therapeutic options, such as monoclonal antibodies, to address the root causes of food allergies and offer more effective solutions for patients. Monoclonal antibodies present a promising strategy for managing food allergies by specifically targeting immune system components involved in allergic reactions, thus providing more precise and potent treatments for individuals. For example, in February 2024, Novartis AG, a pharmaceutical company located in Switzerland, secured FDA approval for Xolair (omalizumab) for the reduction of IgE-mediated food allergies. This humanized monoclonal antibody is administered subcutaneously and functions by preventing the binding of IgE antibodies, subsequently reducing the release of chemicals that cause allergy symptoms. The FDA’s approval stems from positive data yielded by the Phase III OUtMATCH study, which indicated that a significantly larger proportion of food allergy patients, including those as young as 1 year, who were treated with Xolair, could tolerate small amounts of peanut, milk, egg, and cashews without an allergic response, compared to those receiving a placebo.

Which Organizations Play A Role In The Food Allergy Treatment Market Landscape?

Major companies operating in the food allergy treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC, Novartis AG, Amgen Inc., Regeneron Pharmaceuticals Inc., ALK-Abelló A/S, Stallergenes Greer, Kaleo Inc., HAL Allergy B.V., Vedanta Biosciences Inc., Aimmune Therapeutics, AnaptysBio Inc., Immunomic Therapeutics Inc., Alladapt Immunotherapeutics Inc., Aravax, Prota Therapeutics Pty Ltd., DBV Technologies, Adamis Pharmaceuticals Corporation

Get The Full Food Allergy Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/food-allergy-treatment-global-market-report

Which Region Dominates The Food Allergy Treatment Market By Market Share?

North America was the largest region in the food allergy treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food allergy treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Food Allergy Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/food-allergy-treatment-global-market-report

Browse Through More Reports Similar to the Global Food Allergy Treatment Market 2026, By The Business Research Company

Allergy Immunotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Allergy Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report

Peanut Allergy Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/peanut-allergy-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795